Identification of a novel TGFβ/pka signaling transduceome in mediating control of cell survival and metastasis in colon cancer

Sanjib Chowdhury, Gillian M. Howell, Ashwani Rajput, Carol A. Teggart, Lisa E. Brattain, Hannah R. Weber, Aparajita Chowdhury, Michael G. Brattain

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Background: Understanding drivers for metastasis in human cancer is important for potential development of therapies to treat metastases. The role of loss of TGFβ tumor suppressor activities in the metastatic process is essentially unknown. Methodology/Principal Findings: Utilizing in vitro and in vivo techniques, we have shown that loss of TGFβ tumor suppressor signaling is necessary to allow the last step of the metastatic process - colonization of the metastatic site. This work demonstrates for the first time that TGFβ receptor reconstitution leads to decreased metastatic colonization. Moreover, we have identified a novel TGFβ/PKA tumor suppressor pathway that acts directly on a known cell survival mechanism that responds to stress with the survivin/XIAP dependent inhibition of caspases that effect apoptosis. The linkage between the TGFβ/PKA transduceome signaling and control of metastasis through induction of cell death was shown by TGFβ receptor restoration with reactivation of the TGFβ/PKA pathway in receptor deficient metastatic colon cancer cells leading to control of aberrant cell survival. Conclusion/Significance: This work impacts our understanding of the possible mechanisms that are critical to the growth and maintenance of metastases as well as understanding of a novel TGFβ function as a metastatic suppressor. These results raise the possibility that regeneration of attenuated TGFβ signaling would be an effective target in the treatment of metastasis. Our work indicates the clinical potential for developing anti-metastasis therapy based on inhibition of this very important aberrant cell survival mechanism by the multifaceted TGFβ/PKA transduceome induced pathway. Development of effective treatments for metastatic disease is a pressing need since metastases are the major cause of death in solid tumors.

Original languageEnglish (US)
Article numbere19335
JournalPloS one
Volume6
Issue number5
DOIs
StatePublished - May 13 2011

Fingerprint

colorectal neoplasms
metastasis
Colonic Neoplasms
cell viability
Tumors
Cell Survival
Cells
Neoplasm Metastasis
neoplasms
Neoplasms
Cell death
receptors
Caspases
Restoration
therapeutics
Apoptosis
caspases
cell death
Regeneration
Cause of Death

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Chowdhury, S., Howell, G. M., Rajput, A., Teggart, C. A., Brattain, L. E., Weber, H. R., ... Brattain, M. G. (2011). Identification of a novel TGFβ/pka signaling transduceome in mediating control of cell survival and metastasis in colon cancer. PloS one, 6(5), [e19335]. https://doi.org/10.1371/journal.pone.0019335

Identification of a novel TGFβ/pka signaling transduceome in mediating control of cell survival and metastasis in colon cancer. / Chowdhury, Sanjib; Howell, Gillian M.; Rajput, Ashwani; Teggart, Carol A.; Brattain, Lisa E.; Weber, Hannah R.; Chowdhury, Aparajita; Brattain, Michael G.

In: PloS one, Vol. 6, No. 5, e19335, 13.05.2011.

Research output: Contribution to journalArticle

Chowdhury, S, Howell, GM, Rajput, A, Teggart, CA, Brattain, LE, Weber, HR, Chowdhury, A & Brattain, MG 2011, 'Identification of a novel TGFβ/pka signaling transduceome in mediating control of cell survival and metastasis in colon cancer', PloS one, vol. 6, no. 5, e19335. https://doi.org/10.1371/journal.pone.0019335
Chowdhury, Sanjib ; Howell, Gillian M. ; Rajput, Ashwani ; Teggart, Carol A. ; Brattain, Lisa E. ; Weber, Hannah R. ; Chowdhury, Aparajita ; Brattain, Michael G. / Identification of a novel TGFβ/pka signaling transduceome in mediating control of cell survival and metastasis in colon cancer. In: PloS one. 2011 ; Vol. 6, No. 5.
@article{30317f5f97e4400db5b04a0ec801c9cb,
title = "Identification of a novel TGFβ/pka signaling transduceome in mediating control of cell survival and metastasis in colon cancer",
abstract = "Background: Understanding drivers for metastasis in human cancer is important for potential development of therapies to treat metastases. The role of loss of TGFβ tumor suppressor activities in the metastatic process is essentially unknown. Methodology/Principal Findings: Utilizing in vitro and in vivo techniques, we have shown that loss of TGFβ tumor suppressor signaling is necessary to allow the last step of the metastatic process - colonization of the metastatic site. This work demonstrates for the first time that TGFβ receptor reconstitution leads to decreased metastatic colonization. Moreover, we have identified a novel TGFβ/PKA tumor suppressor pathway that acts directly on a known cell survival mechanism that responds to stress with the survivin/XIAP dependent inhibition of caspases that effect apoptosis. The linkage between the TGFβ/PKA transduceome signaling and control of metastasis through induction of cell death was shown by TGFβ receptor restoration with reactivation of the TGFβ/PKA pathway in receptor deficient metastatic colon cancer cells leading to control of aberrant cell survival. Conclusion/Significance: This work impacts our understanding of the possible mechanisms that are critical to the growth and maintenance of metastases as well as understanding of a novel TGFβ function as a metastatic suppressor. These results raise the possibility that regeneration of attenuated TGFβ signaling would be an effective target in the treatment of metastasis. Our work indicates the clinical potential for developing anti-metastasis therapy based on inhibition of this very important aberrant cell survival mechanism by the multifaceted TGFβ/PKA transduceome induced pathway. Development of effective treatments for metastatic disease is a pressing need since metastases are the major cause of death in solid tumors.",
author = "Sanjib Chowdhury and Howell, {Gillian M.} and Ashwani Rajput and Teggart, {Carol A.} and Brattain, {Lisa E.} and Weber, {Hannah R.} and Aparajita Chowdhury and Brattain, {Michael G.}",
year = "2011",
month = "5",
day = "13",
doi = "10.1371/journal.pone.0019335",
language = "English (US)",
volume = "6",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "5",

}

TY - JOUR

T1 - Identification of a novel TGFβ/pka signaling transduceome in mediating control of cell survival and metastasis in colon cancer

AU - Chowdhury, Sanjib

AU - Howell, Gillian M.

AU - Rajput, Ashwani

AU - Teggart, Carol A.

AU - Brattain, Lisa E.

AU - Weber, Hannah R.

AU - Chowdhury, Aparajita

AU - Brattain, Michael G.

PY - 2011/5/13

Y1 - 2011/5/13

N2 - Background: Understanding drivers for metastasis in human cancer is important for potential development of therapies to treat metastases. The role of loss of TGFβ tumor suppressor activities in the metastatic process is essentially unknown. Methodology/Principal Findings: Utilizing in vitro and in vivo techniques, we have shown that loss of TGFβ tumor suppressor signaling is necessary to allow the last step of the metastatic process - colonization of the metastatic site. This work demonstrates for the first time that TGFβ receptor reconstitution leads to decreased metastatic colonization. Moreover, we have identified a novel TGFβ/PKA tumor suppressor pathway that acts directly on a known cell survival mechanism that responds to stress with the survivin/XIAP dependent inhibition of caspases that effect apoptosis. The linkage between the TGFβ/PKA transduceome signaling and control of metastasis through induction of cell death was shown by TGFβ receptor restoration with reactivation of the TGFβ/PKA pathway in receptor deficient metastatic colon cancer cells leading to control of aberrant cell survival. Conclusion/Significance: This work impacts our understanding of the possible mechanisms that are critical to the growth and maintenance of metastases as well as understanding of a novel TGFβ function as a metastatic suppressor. These results raise the possibility that regeneration of attenuated TGFβ signaling would be an effective target in the treatment of metastasis. Our work indicates the clinical potential for developing anti-metastasis therapy based on inhibition of this very important aberrant cell survival mechanism by the multifaceted TGFβ/PKA transduceome induced pathway. Development of effective treatments for metastatic disease is a pressing need since metastases are the major cause of death in solid tumors.

AB - Background: Understanding drivers for metastasis in human cancer is important for potential development of therapies to treat metastases. The role of loss of TGFβ tumor suppressor activities in the metastatic process is essentially unknown. Methodology/Principal Findings: Utilizing in vitro and in vivo techniques, we have shown that loss of TGFβ tumor suppressor signaling is necessary to allow the last step of the metastatic process - colonization of the metastatic site. This work demonstrates for the first time that TGFβ receptor reconstitution leads to decreased metastatic colonization. Moreover, we have identified a novel TGFβ/PKA tumor suppressor pathway that acts directly on a known cell survival mechanism that responds to stress with the survivin/XIAP dependent inhibition of caspases that effect apoptosis. The linkage between the TGFβ/PKA transduceome signaling and control of metastasis through induction of cell death was shown by TGFβ receptor restoration with reactivation of the TGFβ/PKA pathway in receptor deficient metastatic colon cancer cells leading to control of aberrant cell survival. Conclusion/Significance: This work impacts our understanding of the possible mechanisms that are critical to the growth and maintenance of metastases as well as understanding of a novel TGFβ function as a metastatic suppressor. These results raise the possibility that regeneration of attenuated TGFβ signaling would be an effective target in the treatment of metastasis. Our work indicates the clinical potential for developing anti-metastasis therapy based on inhibition of this very important aberrant cell survival mechanism by the multifaceted TGFβ/PKA transduceome induced pathway. Development of effective treatments for metastatic disease is a pressing need since metastases are the major cause of death in solid tumors.

UR - http://www.scopus.com/inward/record.url?scp=79955783609&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955783609&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0019335

DO - 10.1371/journal.pone.0019335

M3 - Article

VL - 6

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 5

M1 - e19335

ER -